deltatrials

Acute myeloid leukemia Trials in Perth, Australia

Conditions / Acute myeloid leukemia / Perth, Australia

Research into Acute myeloid leukemia spans multiple therapeutic approaches and trial phases.

19 total trials for this combination

Showing top 10 of 19 trials

Trials

NCT ID Title Status Phase
NCT00260832 Trial of Decitabine in Patients With Acute Myeloid Leukemia COMPLETED PHASE3
NCT00079482 Study of CEP-701 (Lestaurtinib) in Patients With Acute Myeloid Leukemia (AML) COMPLETED PHASE2
NCT03151408 An Efficacy and Safety Study Of Pracinostat In Combination With Azacitidine In Adults With Acute Myeloid Leukemia TERMINATED PHASE3
NCT04726241 The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study RECRUITING PHASE1/PHASE2
NCT02785900 Vadastuximab Talirine (SGN-CD33A; 33A) Combined With Azacitidine or Decitabine in Older Patients With Newly Diagnosed Acute Myeloid Leukemia TERMINATED PHASE3
NCT04293562 A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations RECRUITING PHASE3
NCT04778397 Study of Magrolimab in Combination With Azacitidine Versus Physician's Choice of Venetoclax in Combination With Azacitidine or Intensive Chemotherapy in Patients With TP53 Mutant Acute Myeloid Leukemia That Have Not Been Treated TERMINATED PHASE3
NCT02521493 Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome ACTIVE_NOT_RECRUITING PHASE3
NCT01191801 Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory AML COMPLETED PHASE3
NCT01371981 Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia ACTIVE_NOT_RECRUITING PHASE3

Related Pages